“We’re Back in the Courts” : Finley on What’s Next for HISA

With Congress passing a short-term bill to fund the government for a matter of days, efforts to include in the full-year omnibus spending bill a legislative fix to the constitutional problems dogging the Horseracing Integrity and Safety Act (HISA) is coming down to the crunch, Friday of next week the deadline to pass such a bill before the make-up of Congress changes shape next year.

So, where does this all leave HISA? The answer resembles a puzzle box shaken onto the floor, with HISA offering limited direction as to how all the pieces fit together.

On Monday, after the Federal Trade Commission (FTC) announced that it had disapproved “without prejudice” the program's anti-doping and medication control (ADMC) rules, HISA CEO Lisa Lazarus–someone who has consistently and admirably fielded public queries–provided some useful insights during an impromptu press conference, especially when it comes to money matters.

Since then, however, HISA has been a closed shop.

“The HISA legal team is exploring all possible legal paths forward. Once we determine the best path to protect the integrity and safety of Thoroughbred racing and its participants we will share those plans,” wrote HISA spokesperson, Mandy Minger, after multiple attempts for comment on a series of questions.

And so, the TDN turned once again to constitutional law expert, Lucinda Finley, for her thoughts on the various winding roads leading away from the Act's current crossroads. There are three important cases to note:

One is the Fifth Circuit Court of Appeals, which found in November that the law as written doesn't afford the FTC enough authority in the rule-making process. If HISA fails to get a stay on the ruling, the decision will go into effect Jan. 10.

The second is a ruling pending in the Sixth Circuit Court of Appeals concerning similar constitutional questions to the Fifth Circuit. It is currently unclear when that ruling will land.

The third is a case in the U.S. District Court of Texas–Northern District, Amarillo Division–which raises several constitutional problems with the law, other than FTC rule-making input.

There is also a fourth HISA-related lawsuit initiated by the states of Louisiana and West Virginia, plus the Jockeys' Guild, but there has been no filing activity in that case since Sept. 7.

Is there a key takeaway from the current state of affairs?

Even if Congress does pass language in the omnibus spending bill fixing the problems raised by the Fifth Circuit–in other words, to cede the FTC greater rule-making authority–don't expect the legal fireworks to simmer down, warned Finley.

“We're back in the courts,” Finley said, pinpointing the case before the Amarillo Federal Court as a potentially nasty looking legal blackthorn for HISA.

No Legislative Fix

Let's begin with the scenario that lawmakers fail to insert language to amend HISA into the year-end omnibus spending bill.

Should that happen, a future legislative fix would be unlikely for months, if not a year, due to a looming political environmental where Congress is unlikely to tackle legislation other than what “it absolutely has to act on,” warned Finley.

“What's likely to happen come January when the new Congress is sworn in, the House is going to suddenly be consumed with all these investigations,” said Finley, about the future Republican-led Congress' promise to pursue investigations into Hunter Biden and others. “I don't expect that there will be much in the way of any legislative activity on anything in the first many months.”

With the FTC disapproving HISA's ADMC rules, the current status-quo will remain in effect come Jan. 1–a hybrid world of HISA racetrack safety rules applied alongside individual state medication regulations.

If HISA is unable to get a stay on the Fifth Circuit Court of Appeals ruling, the decision will go into effect Jan. 10.

The question then is: How applicable is the ruling? National? Or just in the states that fall under the Fifth Circuit's jurisdiction, namely Louisiana, Texas and Mississippi.

“HISA is not commenting on legal hypotheticals or speculating on how the ruling might be applied,” wrote Minger, when pressed to provide a clear answer.

According to Finley, the Fifth Circuit ruling applies only in those three states. However, she believes it would be “extremely prudent” for HISA to suspend the racetrack safety rules if indeed a stay is not found on the Fifth Circuit ruling, due to the likelihood of litigation by any sanctioned parties.

“As a practical matter,” said Finley, “it does tie their hands everywhere.”

Failure to gain a legislative fix in the near-term would also place emphasis on the Sixth Circuit's pending ruling.

Should the three-person panel of Sixth Circuit judges rule consistently with the Fifth Circuit, then it is unlikely the Supreme Court would take up the case, given the harmony in Circuit Court decisions.

In other words, there would be no judicial dispute for the Supreme Court to resolve.

A Sixth Circuit ruling favorable to HISA–and in opposition to the Fifth Circuit ruling–would make it more likely the Supreme Court would hear the case, however.

If petitions for a writ of certiorari are filed in both cases–these are the legal devices with which to seek U.S. Supreme Court review of a case–then that court could grant certiorari in one or both.

As for a possible timeframe, if petitions are filed in the spring of 2023 and the Supreme Court decides to review the case, then a final decision might not come until June of 2024.

A Successful Legislative Fix

But let's run with the scenario that next week, lawmakers indeed insert language into the year-end spending bill that affords the FTC greater law-making authority. What then?

First off, HISA could resubmit the ADMC rules with the FTC. It would then take approximately 60 days for these rules to go into effect, “assuming that the FTC was going to approve them substantively,” Lazarus explained, last Monday.

Secondly, it would essentially render the current cases before the Fifth and Sixth Circuits legally moot in a practical sense, and would make the possibility of the Supreme Court taking them up altogether highly unlikely.

Which brings us to the case before the Amarillo Federal Court.

That case raises several additional constitutional arguments that the Fifth and Sixth Circuits did not rule on, including HISA's investigative, subpoena and punishment power as a private body, and the way in which individuals on the HISA board are appointed, said Finley.

“It argues that the whole structure is a delegation of not only too much executive authority, but can amount to a delegation of legislative and judicial authority as well,” Finley explained.

What's more, the district court judge in question, Matthew Kacsmaryk, is one of the “most extreme right-wing” of President Trump's appointed judges.

This leads to an important legal wrinkle in this case with potentially huge implications for HISA.

If judge Kacsmaryk agrees that HISA indeed delegates too much power to a private entity, the plaintiffs in the case are seeking an injunction to suspend enforcement of the law, said Finley.

Would such an injunction apply nationwide or just in Texas?

“You've actually asked what is one of the most raging controversies in U.S. law,” Finley replied. “It used to be extremely rare for a district court federal judge to enjoin the enforcement of a statute or regulatory scheme throughout the whole country,” she said. “They would traditionally just issue an injunction that pertained to the parties in the case.”

Come President Obama's tenure, however, “Republican state attorneys general started suing to stop various programs that the Obama administration wanted to implement. They went to what they thought were favorable district courts, and they started asking them to issue a nationwide injunction saying, 'Look judge, if the statute is unconstitutional or the rules are in violation of federal law, well, we shouldn't allow them to go into effect anywhere,'” explained Finley.

“And judges started buying this argument,” Finley added, explaining that during the Biden administration, Republican attorneys general have attempted to introduce in U.S. district courts nationwide injunctions on cases related to vaccine mandates and immigration rules.

“Groups that want to challenge whatever federal statute or regulatory scheme know what judges they can get their case before to maximize their chances of getting the statute declared unconstitutional, and with a nationwide injunction,” said Finley. “This judge in Amarillo is one of them.”

It appears likely the case currently before the Amarillo Federal Court will end up before the Fifth Circuit Court of Appeals–and then, potentially, the Supreme Court.

“You could get a very different panel,” Finley responded, when asked which way the Fifth Circuit would rule in that case. “But looming over any subsequent appeal to the Fifth Circuit is the fact that it already found a significant part of the [HISA] statute to be unconstitutional.”

The Horizon?

Finley suspects that if HISA's proponents remain firmly resolved to the pursuit of uniformity through a federal body, ongoing legal challenges to HISA might ultimately lead to an end point even more unpalatable to the law's critics–a governmental commission insulated from industry wants and concerns.

“This goes back to my initial point,” said Finley. “Be careful what you wish for.”

As an example, Finley pointed to the relationship between the governmental Securities and Exchange Commission (SEC) and the private Financial Industry Regulatory Authority (FINRA), together providing a watchdog over the nation's financial institutions.

While FINRA provides the SEC with input in the rule-making process, the SEC wields tremendous independent authority with its own enforcement and investigatory staff of government lawyers, Finley explained.

“The more these legal challenges to the HISA statute on the grounds that it delegates too much rulemaking or investigation and enforcement authority to a private body,” said Finley, “it means that the proponents of uniform national regulation are left with the option of creating a government agency to do that uniform regulation and enforcement.”

Critics of HISA, however, are keen that never happens.

The National Horsemen's Benevolent and Protective Association (HBPA) issued an open letter to the industry Thursday, taking aim at HISA and the private Authority for “too many flaws, missteps and costs that could have been averted with true inclusion and transparency in its development.”

The HBPA urged industry stakeholders to build its own set of uniform rules, independent of HISA.

“That includes the National HBPA, America's largest organization representing Thoroughbred owners and trainers; the Association of Racing Commissioners International [ARCI], whose years of hard work on model rules should be the starting point rather than largely ignored; the racetrack veterinarians, and the Jockeys' Guild,” the letter states.

Those in agreement are urged to sign onto the open letter here.

Kentucky lawmaker, Damon Thayer, is looking to resuscitate a bill passed into law by the state legislature in 2011. “It allows Kentucky to participate in an interstate compact, where a group of states can work together on laws pertaining to horseracing,” said Thayer.

The 2011 Kentucky bill allows member states “to act jointly and cooperatively to create more uniform, effective, and efficient practices, programs, rules, and regulations relating to live pari-mutuel horse or greyhound racing and to pari-mutuel wagering activities, both on-track and off-track, that occur in or affect a member state.”

To join on, each individual state would have to pass a similar interstate compact law.

“We could just take a handful of states to start off,” Thayer said, pointing to the major racing jurisdictions of Kentucky, California, New York and Florida.

“If we could get the ARCI or the National HBPA to take the lead on this, we could get something going,” he added. “I don't just want to be a critic of HISA. I want to be a critic of HISA who's offering another alternative.”

How would this venture differ from previously failed attempts at full nationwide uniformity, like the National Uniform Medication Program (NUMP)?

“That would be a good place to start,” Thayer replied, about the NUMP rules as a baseline for the compact's medication program. “But I think now that we've seen the other option, which is of federal legislation–now that it's here, they might be motivated to try something different that's led by the states.”

At the end of the day, warned Finley, the longer the industry continues without uniformity, the more susceptible it grows to attacks from outside groups on its ethical integrity.

As Finley says, “it's about convincing the public that there are national regulations with their focus on equine and human safety and welfare, and that there is serious meaningful enforcement of those rules at a national level with real investigatory power behind it.”

The post “We’re Back in the Courts” : Finley on What’s Next for HISA appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Open Letter to the Industry: We’ll Push for Positive Change, Flawed HISA is Not Answer

The National HBPA was approached by trainers Wesley Ward and Larry Rivelli to help facilitate this open letter to the industry. While this is being distributed by the National HBPA, which also assisted in putting the letter together, the sentiments are those of trainers Wesley Ward, Larry Rivelli and the undersigned horsemen and racing participants. They encourage others who agree with this letter to add their name by using the link here and below. More than 400 have signed up in 24 hours just from word of mouth. Because of time constraints, not all the names have been uploaded to the document (linked to here and elsewhere)–but they will be.

We, the undersigned, commit to being part of the solution in making the industry we love better, safer and improved for the three entities that make it all possible: horseplayers, horse owners and especially the horses.

In that regard, we believe the Horse Racing Integrity & Safety Act and the private Authority to which it delegates governmental powers has too many flaws, missteps and costs that could have been averted with true inclusion and transparency in its development.

Time and time again over the last several years, trainers have been asked to change. When those changes were for the good of the horse and the industry, we changed and adapted without any questioning. We now need to rally together for additional true, positive and lasting change for the good then we are ready to do just that.

However, meaningful change cannot be accomplished until the leadership of all stakeholders have real representation at the table–and from the beginning. That includes the National HBPA, America's largest organization representing Thoroughbred owners and trainers; the Association of Racing Commissioners International, whose years of hard work on model rules should be the starting point rather than largely ignored; the racetrack veterinarians, and the Jockeys' Guild.

We have the opportunity now to get this right, with the 5th Circuit Court of Appeals unanimously ruling HISA unconstitutional and the Federal Trade Commission declining to approve HISA's drug and medication rules that were to go into effect Jan. 1.

HISA is a wake-up call for the hard work of transformative change, though it is unfair to say there has been no change over the past couple of decades. There is far more uniformity than differences among racing jurisdictions.

Horsemen, including the National HBPA and its affiliates, have championed uniform rules based on science for years. Change in horse racing has come rapidly when it makes sense and truly is for the better of the industry. How quickly did it take us to get rid of anabolic steroids? Very.

We know horsemen can no longer sit on the sidelines, as many have done in the past, to now get this done right. We need to speak up, because we are experiencing the consequences when we do not.

We are extremely concerned about the price tag of HISA threatening to put small tracks and small stables out of business because, simply put, they cannot afford the cost. Horse racing cannot survive on only the largest circuits and with only the largest stables. We need venues for all classes of horses and all sizes of stables in order to support a healthy, sustainable Thoroughbred industry.

Small tracks and stables are a vital part of American racing's fabric, developing race fans and generations of future horsemen, and should not be considered as simply collateral damage.

Among other things we believe should be part of the dialogue as we work together:

There must be transparency and representation in both developing and executing the rules.

We, too, want stiff penalties for those succeeding in or attempting to circumvent the rules. But we also believe in due process.

Drug and medication policies that reflect the world in which we live, including the reality of environmental transfer and contamination of impermissible substances in trace levels that don't impact a horse's performance. We need to take a page from human testing, with reasonable, science-based screening levels.

“Gotcha” chemistry–finding a substance in single-digit picograms (parts per trillion) because today's advance testing can–that ensnares innocent parties is not helpful. One source of any negative public perception of racing is because some in leadership have conflated beneficial therapeutic medications with illegal drugs.

Horsemen and jockeys must have more say in developing safety rules, including crop regulations. While science is important, racing will only benefit from policies that allow for input from horsemen and veterinarians in the trenches.

We don't need cost-prohibitive government overreach with burdensome paperwork that takes away from what should be our main focus: our horses.

We, the undersigned, are committing today to push our fellow horsemen, racetracks and racing regulators to unite for positive, inclusive change. We've gotten our wake-up call. We look forward to working with the other stakeholders in our great industry for change done right.

The post Open Letter to the Industry: We’ll Push for Positive Change, Flawed HISA is Not Answer appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

FTC Delays Implementation of HISA’s Drug and Doping Program

In an order Monday, the Federal Trade Commission (FTC) announced that the Horseracing Integrity and Safety Act's (HISA) anti-doping and medication control (ADMC) program would not go into effect as scheduled Jan. 1 due to swirling legal uncertainty.

“The bedrock principle of the Act is the need for uniformity,” wrote the FTC in the order, adding that “the Commission's approval of the Anti-Doping and Medication Control proposed rule would not result in uniformity because the Horseracing Integrity and Safety Act has been held unconstitutional by a panel of the United States Court of Appeals for the Fifth Circuit.”

Oral arguments similarly surrounding HISA's facial constitutionality were held last week in a separate case before the Sixth Circuit Court of Appeals.

“The Commission therefore disapproves the proposed rule without prejudice. If the legal uncertainty regarding the Act's constitutionality comes to be resolved, the Authority may resubmit the proposed rule or a similar rule, and the Commission will consider all comments filed in this proceeding as well as any updated or new comments and filings.

“In the meanwhile, and until any future proposed rule on the subject is approved by the Commission, State law will continue to regulate the matters that the proposed rule would have covered,” the order states.

According to HISA's CEO Lisa Lazarus, who held an impromptu press conference Monday afternoon, this means that the current regulatory “status quo” will remain in place at the start of 2023.

“They made reference to the fact that, since the FTC has not approved any ADMC rules under HISA's authority, that means all the state rules remain in full force and effect,” said Lazarus, stressing that this was her “interpretation” of the FTC order.

“If there wasn't a clear statement on this issue quickly, then we might get to Jan. 1, and there might be some uncertainty around who actually has the authority. It's important for the states to know now that they're going to continue to be the ones in charge of testing on Jan. 1,” Lazarus added.

When it comes to the financial implications from Monday's announcement, HISA will refrain from collecting any of the 2023 fee assessments, designated for the individual states or, alternately, the racetracks, said Lazarus.

“The vast majority of those fees relate to the anti-doping program,” said Lazarus, explaining that the 2023 fees will be collected once the legal uncertainty has been resolved.

“There are still assessments being paid for 2022 that obviously are still required for the state racing associations who opted in, and the racetracks to cover, because those costs have already been incurred, or are in the process of being incurred,” she added.

Ben Mosier, executive director of the Horseracing Integrity & Welfare Unit (HIWU), the enforcement arm of HISA's ADMC program, released a statement explaining that HIWU will continue its education and outreach efforts “to all stakeholders in the Thoroughbred industry,” despite the delay in implementation.

“As HISA re-submits the draft ADMC rules for the FTC's approval, HIWU will use any additional time before implementation as an opportunity to ensure the industry is even more prepared for an efficient rollout of this Program, which will promote fair competition in the sport of Thoroughbred racing and the safety and welfare of our human and equine athletes,” wrote Mosier.

According to Lazarus, “So long as that preparatory work doesn't extend beyond two to three months, [HIWU's work] would still be covered by the 2022 budget.” However, “if it extends longer, we would have to revisit that issue.”

As for potential timelines moving forward, Lazarus explained that once the ADMC rules have been resubmitted with the FTC, it would take approximately 60 days for them to then go into effect, “assuming that the FTC was going to approve them substantively.”

Lazarus also broached a number of different scenarios in what appears to many in the industry a swirling morass of unpredictability and confusion.

Last month, the Fifth Circuit Court of Appeals found the law facially unconstitutional due to the lack of rule-making authority ceded to the FTC. That mandate is set to go into effect Jan. 10.

But if HISA is able to secure a stay on the Fifth Circuit's ruling in the interim, “we would then go back to the FTC [with the ADMC rules] and seek approval on that basis,” said Lazarus.

A similar case questioning HISA's constitutionality is also before the Sixth Circuit Court of Appeals. According to Lazarus, a ruling in the Sixth Circuit is expected “in the next month or two.”

If the Sixth Circuit issues a ruling favourable to HISA, “it would potentially give us the ability to continue with our program in those jurisdictions the Sixth Circuit covers,” said Lazarus.

“And it would also potentially lead to the [U.S.] Supreme Court hearing the case,” said added.

Nevertheless, even if the Sixth Circuit issues a friendly ruling on HISA, the FTC still might prove reluctant to allow HISA's ADMC to go into effect in those jurisdictions as the new law wouldn't be implemented uniformly, said Lazarus.

“For that reason, it's very possible the FTC would maintain the position that we shouldn't resubmit our rules until we have clear ability to move forward and launch across the whole country,” said Lazarus.

Another potential fix to the current knot of legal problems is a congressional re-write of the rules to cede more rule-making power to the FTC. Lazarus declined to speculate on the likelihood and possibility of that option.

A number of experts have questioned whether the legal uncertainty surrounding HISA's constitutionality puts into jeopardy the law's racetrack safety rules, already in effect. Lazarus said that Monday's order has no effect on the racetrack safety prong of the program.

“This related solely to the ADMC rules, and also, it was not a substantive review,” said Lazarus. “It was a statement on their perspective with regards to the legal uncertainties and ensuring there's clarity before we launch the new program.”

Ed Martin, the Association of Racing Commissioners International's (ARCI) president and CEO, referenced a letter the organization sent last week to the FTC highlighting “a real Catch-22” come Jan.1 concerning the legality of HISA's ADMC program.

“We are appreciative that the FTC listened and considered the request of the Association of Racing Commissioners International not to create regulatory uncertainty on Jan. 1 by approving the proposed HISA rules,” Martin told the TDN.

“Whoever got brought up on a charge could potentially have appealed it ad nauseam, and maybe win, which means there might be no rules in effect. That was the danger here,” Martin speculated. “They might be mad at me for bringing it up, but it needed to be brought up.”

The following is HISA's full statement in response to the FTC order:

“HISA appreciates the Federal Trade Commission's (FTC) decision to deny HISA's draft Anti-Doping and Medication Control (ADMC) rules without prejudice as we actively seek to resolve current legal uncertainties. HISA is eager to launch Thoroughbred racing's first and long-awaited national, uniform ADMC program and stands ready to do so. We will re-submit the draft ADMC rules to the FTC for their review as soon as these legal uncertainties are resolved, and once approved, we will implement the program through the Horseracing Integrity and Welfare Unit (HIWU). In the meantime, HIWU will continue to work toward the implementation of a uniform, independent anti-doping and medication control program that is administered consistently and fairly across the United States.”

In a statement, National HBPA CEO Eric Hamelback wrote, “The recent FTC decision is another positive step forward for horsemen in our battle against the unconstitutional takeover of our industry. The strength of our legal arguments led to a unanimous decision in the Fifth Circuit, and now the FTC has done the right thing in declining to defy a federal court that has found HISA unconstitutional. The FTC order is clear: state law continues to govern medication issues until our final victory in this case.”

 

The post FTC Delays Implementation of HISA’s Drug and Doping Program appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

HISA CEO at Symposium: ‘To External Threats, We Need to Speak in One Voice’

Lisa Lazarus, the chief executive officer for the Horseracing Integrity and Safety Authority (HISA), on Tuesday made an appeal for sport-wide unity with United States racing on the cusp of a Jan. 1 roll-out of HISA's Anti-Doping and Medication Control rules.

“I want you to think about what this sort of change is going to mean for the industry,” Lazarus said. “It's going to look and feel different, and it's going to allow us to say to those that are our detractors, to those that doubt horse racing is clean, 'Look, we now have a rigorous, comprehensive program that is uniform; where laboratories are harmonized.'”

Lazarus made her remarks as part of the kickoff to the 2022 Global Symposium on Racing hosted by the University of Arizona Race Track Industry Program in Tucson, Arizona. She briefly acknowledged, but did not dwell upon, the looming legal fight that HISA faces that could derail its very existence.

The U.S. Court of Appeals for the Fifth Circuit on Nov. 18 ruled that HISA is unconstitutional, and the Sixth Circuit Appeals Court will hear oral arguments Dec. 7 in a similar case that also seeks to reverse a lower court's decision to dismiss a constitutional challenge.

Although petitions for legal stays, rehearings, or potential actions by Congress are all in play for the near future, HISA is otherwise operating in business-as-usual mode until an expected Jan. 10 mandate gets issued by the Fifth Circuit to enforce its order. So in that spirit, Lazarus kept her Dec. 6 remarks forward-focused.

“One of two things are going to happen,” Lazarus said. “Either we're going to be able to show, and I think we will, that the vast majority of racehorses are competing clean. And if we have [drug] positives, we'll be able to show that we're now taking significant action, that we're now on our own initiative cleaning things up. So this, to me, is a game-changer.”

Lazarus said she would like industry stakeholders to think of HISA as a “stabilizer.” She gave the analogy of a stable stock market, in which that stability allows growth to occur.

Lazarus also mentioned a couple of ways in which she didn't want stakeholders to think of HISA: Not, she said, as an entity “making rules that complicate people's lives. Not to being sort of a top-down regulator. But genuinely helping to grow the industry through creating uniformity; through creating this protective sheath around issues of integrity and safety.”

Wrapping up, Lazarus underscored the need for unity.

“We need to be united as an industry. We can fight, and scream, and yell, and debate and malign behind closed doors. But to the outside public, to the external threats, we need to speak in one voice,” Lazarus said.

“This is our moment in time. This moment is very unlikely ever to replicate itself,” Lazarus said. “We can't lose this moment in time.”

The post HISA CEO at Symposium: ‘To External Threats, We Need to Speak in One Voice’ appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights